Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - Deferred ChargesAmortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateWages, Salaries and Other
Others
Ratios

Cellebrite DI (CLBT) Amortization - Deferred Charges: 2023-2024

Historic Amortization - Deferred Charges for Cellebrite DI (CLBT) over the last 2 years, with Dec 2024 value amounting to $332.9 million.

  • Cellebrite DI's Amortization - Deferred Charges rose 252.13% to $670.0 million in Q4 2024 from the same period last year, while for Dec 2024 it was $332.9 million, marking a year-over-year increase of 205.97%. This contributed to the annual value of $332.9 million for FY2024, which is 205.97% up from last year.
  • Latest data reveals that Cellebrite DI reported Amortization - Deferred Charges of $332.9 million as of FY2024, which was up 205.97% from $108.8 million recorded in FY2023.
  • Cellebrite DI's Amortization - Deferred Charges' 5-year high stood at $332.9 million during FY2024, with a 5-year trough of $108.8 million in FY2023.
  • Its 2-year average for Amortization - Deferred Charges is $220.8 million, with a median of $220.8 million in 2023.
  • Data for Cellebrite DI's Amortization - Deferred Charges shows a peak YoY skyrocketed of 205.97% (in 2024) over the last 5 years.
  • Cellebrite DI's Amortization - Deferred Charges (Yearly) stood at $108.8 million in 2023, then skyrocketed by 205.97% to $332.9 million in 2024.